Nicholas Company, Inc. Gilead Sciences, Inc. Transaction History

Nicholas Company, Inc.

$5.89 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $24.1 Million - $27.5 Million	-401,255 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $7,141 - $8,979	115 Added 0.03%	401,255 $25.4 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $940,420 - $1.09 Million	-13,000 Reduced 3.14%	401,140 $30.9 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $6.86 Million - $8.79 Million	-109,535 Reduced 20.92%	414,140 $31 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $317,343 - $349,067	5,150 Added 0.99%	523,675 $34 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $125,020 - $138,000	2,000 Added 0.39%	518,525 $32.9 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $309,040 - $346,553	4,995 Added 0.98%	516,525 $34.9 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $298,268 - $334,138	4,770 Added 0.94%	511,530 $33.3 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $817,290 - $1.07 Million	13,500 Added 2.74%	506,760 $31.7 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $5.19 Million - $5.74 Million	72,745 Added 17.3%	493,260 $38.1 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $6.79 Million - $7.92 Million	-104,625 Reduced 19.92%	420,515 $29.8 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $5.95 Million - $7.26 Million	-81,745 Reduced 13.47%	525,140 $39.6 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $529,000 - $620,971	-7,435 Reduced 1.21%	606,885 $43.5 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $16.4 Million - $19.4 Million	-227,135 Reduced 26.99%	614,320 $49.8 Million
Q2 2017 Aug 11, 2017	BUY	N/A	841,455	841,455 $59.6 Million

Others Institutions Holding GILD

# of Institutions

1,878

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.68 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.4 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.07 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.98 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account